NewLink Genetics says working on Zika vaccine

Your Health Matters

(Reuters) – U.S. drug developer NewLink Genetics Corp joined the race to develop a vaccine for the Zika virus, a day after the World Health Organization declared the mosquito-borne disease an international public health emergency. NewLink said on Tuesday it had initiated a project to develop new treatment options for the disease. NewLink is also developing an ebola vaccine with Merck that has proved to be highly effective against the deadly virus in a large trial in Guinea.
Go to Source

facebookShare on Facebook
TwitterTweet
FollowFollow us
PinterestSave